The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

HeartWare to Present at the Lazard Capital Markets 7th Annual Healthcare Conference

November 11, 2010 1:33 pm | by Bio-Medicine.Org | News | Comments

FRAMINGHAM, Mass. and SYDNEY, Nov. 11, 2010 /- HeartWare International, Inc. (Nasdaq: HTWR ; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug...


Cardica Announces Fiscal 2011 First Quarter Financial Results

November 11, 2010 1:33 pm | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif., Nov. 11, 2010 /- Cardica, Inc. (Nasdaq: CRDC ) today announced financial results for its fiscal first quarter ended September 30, 2010. Cardica's management will host a conference call at 4:30 p.m. Eastern Time today to discuss the financial results and provide an...


23 percent of young people get into fights when they go out at night

November 11, 2010 12:35 pm | by EurekAlert | News | Comments

(FECYT - Spanish Foundation for Science and Technology) Night-time violence among young Spaniards is becoming ever more common, according to a research study carried out by the European Institute of Studies on Prevention. The study shows that 5.2 percent of young people carry...


Fruit flies lead scientists to new human pain gene

November 11, 2010 11:35 am | by EurekAlert | News | Comments

(Children's Hospital Boston) While it has become clear in recent years that susceptibility to pain has a strong inherited component, very little is known about actual "pain genes" and how they work. In the Nov. 12 issue of Cell, researchers at Children's Hospital Boston and their...


Contact among age groups key to understanding whooping cough spread and control

November 11, 2010 10:36 am | by EurekAlert | News | Comments

(University of Michigan) Strategies for preventing the spread of whooping cough -- on the rise in the United State -- should take into account how often people in different age groups interact, research at the University of Michigan suggests.


Norway Selects IBM to Create Smarter Healthcare Infrastructure

November 11, 2010 10:35 am | by IBM | News | Comments

At the Smarter Industries Symposium today in Barcelona, IBM announced it has entered into an agreement with Central Norway Regional Health Authority to provide information technology to support all hospitals in Norway and improve coordination and reporting of health information, logistics...

Modulight releases OEM laser systems for Medical and Industrial applications.

November 11, 2010 9:37 am | by I-Micronews | News | Comments

Modulight announced today a set of single-emitter based OEM laser systems ideal for medical and industrial applications.

Spencer Pharmaceutical buyout bid priced at $245M

November 11, 2010 9:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Spencer Pharmaceutical Inc., a metabolic disease-focused firm in Boston, has announced that the unsolicited cash buyout offer it received last week is priced at 97 cents per share, which could bring the company $245 million.


Testing Autism Drugs in Human Brain Cells

November 11, 2010 9:36 am | by Massachusetts Institute of Technology | News | Comments

A method involving pluripotent stem cells could lead to personalized treatment of the disease.

FDA approves treatment for HIV-linked abdominal fat

November 11, 2010 9:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

The U.S. Food and Drug Administration has approved a treatment, developed by Canadian firm Theratechnologies and marketed exclusively in the U.S. by Rockland-based EMD Serono, for excess abdominal fat in HIV-infected patients with lipodystrophy.


New Analyses of Data From RE-LY Trial, Involving Oral Anticoagulant Pradaxa, to be Presented at American Heart Association's Scientific Sessions

November 11, 2010 9:35 am | by Bio-Medicine.Org | News | Comments

RIDGEFIELD, Conn., Nov. 11, 2010 /- Results of two pre-specified sub-study analyses of the 18,113 patient RE-LY® trial,(1) involving the newly approved oral anticoagulant Pradaxa® (dabigatran etexilate mesylate) capsules,(2) will be presented at the American Heart Association's...


Novartis halts lung cancer trial

November 11, 2010 9:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Novartis AG said it is discontinuing late stage clinical trials for a drug candidate to treat lung cancer because the trial was unlikely to meet its endpoint.


Dehaier Medical Announces Conference Call to Discuss Third Quarter 2010 Financial Results

November 11, 2010 9:34 am | by Bio-Medicine.Org | News | Comments

BEIJING, Nov. 11, 2010 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM ) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it will hold...


Mindray Medical to Exhibit at MEDICA 2010 in Dusseldorf, Germany from November 17- 20, 2010

November 11, 2010 9:34 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, Nov. 11, 2010 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR ), a leading developer, manufacturer and marketer of medical devices worldwide, today announced its participation in the MEDICA 2010 42nd World Forum of Medicine International...


IPC buys Nevada doctor group for undisclosed sum

November 11, 2010 6:45 am | by The Associated Press | News | Comments

IPC The Hospitalist Company Inc. said Thursday it bought the Las Vegas physician group practice Zenith Hospitalists. Terms of the deal were not disclosed.IPC, a physician group practice company, said the deal expands its presence in a Nevada market where it is already well-established. Zenith...


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.